Literature DB >> 12692674

Multiple coexistent dysraphic pathologies.

Guirish A Solanki1, James Evans, Andrew Copp, Dominic N P Thompson.   

Abstract

INTRODUCTION: Four distinct dysraphic anomalies were observed in a single child. While combinations of such anomalies are well recognised, quadruple dysraphic pathology, nevertheless, is extremely uncommon. To our knowledge, no previous cases have been reported in the literature. CASE REPORT: We present the management of a child with a concurrent segmental meningocele, a type-1 split cord malformation (SCM) associated with hemivertebrae, lipomyelomeningoceles in each hemicord of the SCM and a terminal myelocystocele, and we review the literature on potential mechanisms of dysmorphogenesis. DISCUSSION: Existing embryologic hypotheses for the dysraphic spectrum lack experimental evidence and studies in animal models. This case challenges the existing hypotheses and illustrates our incomplete understanding of human terminal spinal cord embryogenesis. Further studies on the morphogenetic basis for these anomalies are required.

Entities:  

Mesh:

Year:  2003        PMID: 12692674     DOI: 10.1007/s00381-003-0728-y

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  12 in total

Review 1.  Neurulation and neural tube closure defects.

Authors:  A Copp; P Cogram; A Fleming; D Gerrelli; D Henderson; A Hynes; M Kolatsi-Joannou; J Murdoch; P Ybot-Gonzalez
Journal:  Methods Mol Biol       Date:  2000

2.  A case of diastematomyelia associated with myeloschisis in a hemicord.

Authors:  T Yamanaka; N Hashimoto; H Sasajima; K Mineura
Journal:  Pediatr Neurosurg       Date:  2001-11       Impact factor: 1.162

Review 3.  The embryonic development of mammalian neural tube defects.

Authors:  A J Copp; F A Brook; J P Estibeiro; A S Shum; D L Cockroft
Journal:  Prog Neurobiol       Date:  1990       Impact factor: 11.685

4.  Cervical diastematomyelia and syringohydromyelia in a myelomeningocele patient.

Authors:  H J Jaeger; A Schmitz-Stolbrink; K D Mathias
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

5.  Hemimyelocele.

Authors:  T Duckworth; W J Sharrard; J Lister; N Seymour
Journal:  Dev Med Child Neurol       Date:  1968       Impact factor: 5.449

6.  Retinoic acid induces down-regulation of Wnt-3a, apoptosis and diversion of tail bud cells to a neural fate in the mouse embryo.

Authors:  A S Shum; L L Poon; W W Tang; T Koide; B W Chan; Y C Leung; T Shiroishi; A J Copp
Journal:  Mech Dev       Date:  1999-06       Impact factor: 1.882

Review 7.  Split cord malformation: Part I: A unified theory of embryogenesis for double spinal cord malformations.

Authors:  D Pang; M S Dias; M Ahab-Barmada
Journal:  Neurosurgery       Date:  1992-09       Impact factor: 4.654

Review 8.  Terminal syringohydromyelia and occult spinal dysraphism.

Authors:  B J Iskandar; W J Oakes; C McLaughlin; A K Osumi; R D Tien
Journal:  J Neurosurg       Date:  1994-10       Impact factor: 5.115

Review 9.  Genetic models of mammalian neural tube defects.

Authors:  A J Copp
Journal:  Ciba Found Symp       Date:  1994

10.  A role for Pax-1 as a mediator of notochordal signals during the dorsoventral specification of vertebrae.

Authors:  H Koseki; J Wallin; J Wilting; Y Mizutani; A Kispert; C Ebensperger; B G Herrmann; B Christ; R Balling
Journal:  Development       Date:  1993-11       Impact factor: 6.868

View more
  3 in total

1.  An accessory limb with lipomyelomeningocele in a male.

Authors:  Robert F Murphy; Brian H Cohen; Michael S Muhlbauer; James W Eubanks; Jeffrey R Sawyer; Alice Moisan; Derek M Kelly
Journal:  Pediatr Surg Int       Date:  2013-02-08       Impact factor: 1.827

Review 2.  Complex forms of spinal dysraphism.

Authors:  Ashis Patnaik; Ashok Kumar Mahapatra
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

3.  Unusual spinal dysraphic lesions.

Authors:  Jose Roberto Tude Melo; Pollyana Pacheco; Luiz Eduardo Wanderley
Journal:  Case Rep Pediatr       Date:  2013-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.